DR. LUKE WART REMOVER

Manufacturer
Dr.luke Healthcare LLC
Effective date
2023-08-10
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
legacy-cache
Hydrated at
2026-08-01 21:27:30

Label at a glance#

ProductDR. LUKE WART REMOVER
Active ingredientSALICYLIC ACID, CHLORHEXIDINE ACETATE
Label structure12 sections

Dosage and administration

●Wash wart and surrounding skin with rubbing alcohol or astringent solution (e.g.: Potassium Permanganate solution), and dry the area thoroughly. ●Apply a small amount of liquid solution onto the wart with a cotton swab, and press the wart 2-3 times. Avoid applying on healthy skin. ●Do not apply the liquid over 1 ml onto the affected area. After applying, let the affected area dry. ●Use once in the morning and eve...

Storage and handling

●Keep away from direct sunlight or heat ●Store in room temperature (59-860F / 15-300C)

Label contents#

Full prescribing information#

Active Ingredient

OTC - ACTIVE INGREDIENT SECTION

Salicylic Acid 1%

Chlorhexidine Acetate 1%

Purpose

OTC - PURPOSE SECTION

Wart Remover; Antiviral

Use

INDICATIONS & USAGE SECTION

For genital wart, and small size common wart, flat wart, filiform wart

Warnings

WARNINGS SECTION

●For external use only.
●Children need to use it under adult supervision.
●Please tighten the cap immediately after using it
●Avoid contact with eyes, flush wtth water immediately if it gets into eyes.
●A small number of users may experience a slight burning or tingling sensation after use.
●Minor rash and swelling reactions may occur, needn't stop using.

Do not use

OTC - DO NOT USE SECTION

If you are pregnant, breastfeeding
If you are allergic to this product
On children under 10 years
On unhealed wounds after surgery

When Using

OTC - WHEN USING SECTION

Stop Use And See A Doctor If
you are experiencing severe allergic reactions, local ulcers, heavy rash, edema or severe pain.
KEEP OUT OF REACH OF CHILDREN

Keep Oot Of Reach Of Children

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Do not place the product within the reach of unconscious persons.

Directions

DOSAGE & ADMINISTRATION SECTION

●Wash wart and surrounding skin with rubbing alcohol or astringent solution (e.g.: Potassium Permanganate solution), and dry the area thoroughly.
●Apply a small amount of liquid solution onto the wart with a cotton swab, and press the wart 2-3 times. Avoid applying on healthy skin.
●Do not apply the liquid over 1 ml onto the affected area. After applying, let the affected area dry.
●Use once in the morning and evening continuously for 7 days. The wart will begin to fall off after the last day of treatment. stop using, and observe for 3 days.
*Repeat the treatment p rocess if the wart has not yet fallen off.
If swallowed, rinse immediately with water, and get medicalhelp or contact a poison control center right away

Other information

STORAGE AND HANDLING SECTION

●Keep away from direct sunlight or heat
●Store in room temperature (59-860F / 15-300C)

Inactive ingredients

INACTIVE INGREDIENT SECTION

Cortex Phellodendri, Chinensis, Radix Isatidis, Radix Arnebiae,Semen Coicis, Carthamus Tinctorius L, Angelica Sinensis,Rhizoma Chuanxiong, Crassostrea Gigas.

PACKAGE LABEL

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

2121

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 13 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
83176-01383176-013-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 10 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
2764b6a4-aed2-2ff8-e063-6394a90aa3f7028bfd58-f397-55b3-e063-6294a90abfef2024-11-20WarningsExact identifier
spl set id: 028bfd58-f397-55b3-e063-6294a90abfef

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.